The present invention provides immunoresponsive cells, including T cells,cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressingat least one of an antigen- recognizing receptor and a co-stimulatory ligandand methods of use therefore for the treatment of neoplasia and other pathologieswhere an increase in an antigen-specific immune response is desired.